Related Experiment Video
Updated: Jun 25, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
An evaluation of the performance of the PAP-PCR method in detecting UGT1A1 gene polymorphisms
Xiangsha Kong1, Bo Feng1, Zixiang Huang2
1Peking University People's Hospital, Peking University Hepatology Institute, Infectious Disease and Hepatology Center of Peking University People's Hospital, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology On NAFLD Diagnosis, Beijing, 100044, China.
Background:
Gilbert's syndrome (GS) is a hereditary disorder caused by mutations in the UGT1A1 gene, leading to unconjugated hyperbilirubinemia. Accurate detection of UGT1A1 gene polymorphisms is crucial for diagnosis and management of GS. This study evaluated the clinical application of pyrophosphorolysis-activated polymerization PCR (PAP-PCR) method in dection of UGT1A1 gene polymorphisms.
Methods And Results:
Whole-blood samples from 53 patients with GS were genotyped using PAP-PCR for UGT1A1 variations, including UGT1A1*60 (c.-3279T > G), UGT1A1*28 ([TA]6 > [TA]7), UGT1A1*6 (c.211G > A, G71R), UGT1A1*27 (c.686C > A, P229Q), UGT1A1*63 (c.1091C > T, P364L), and UGT1A1*7 (c.1456T > G, Y486D). For each locus, all cases were verified using the direct sequencing to assess PAP-PCR precision. One mutation type per locus was selected to investigate reproducibility and detection limits. The UGT1A1 gene polymorphism detected using PAP-PCR showed that, among the 53 patients, 83.02% presented missense mutations at UGT1A1*60 (c.-3279T > G), 54.72% had heterozygous or homozygous insertions in the TATA box in the promoter, 52.38% had the UGT1A1*6 variant (c.211G > A, G71R). The results obtained using the PAP-PCR and direct sequencing methods were almost consistent among all patients with UGT1A1 gene variants. However, there were different results in the promoter region variants among 2 patients in which PAP-PCR showed [TA]7 homozygosity, whereas direct sequencing revealed [TA]7/[TA]6 heterozygosity. This inconsistent result had been confirmed to be caused by differences in DNA polymerase activity.
Conclusions:
PAP-PCR could effectively detect UGT1A1 gene polymorphisms associated with Gilbert's syndrome. And it had exhibited superior accuracy in the analysis of TA repeat sequences compared to direct sequencing method. Additionally, due to its reduced program complexity, easy execution, and simple standardization, PAP-PCR may be a highly favorable option for clinical diagnosis.
Related Concept Videos
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

